Price range: $185.00 through $275.00
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) and modified for enhanced stability. In research environments, Semax is studied for its influence on neurotrophic signaling, cognitive pathway modulation, and neuroprotective frameworks.
Within controlled laboratory models, Semax is evaluated for its interaction with BDNF expression, dopaminergic transmission, and stress-response signaling dynamics.
Research Name: Semax
Category: Neurotrophic regulatory peptide
Primary Research Focus: Cognitive signaling, BDNF modulation, neuroprotective pathway analysis
Format: Lyophilized powder
Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary depending on total diluent added. Researchers calculate concentration using the standard formula:
Total mg in vial ÷ Total mL added = mg per mL
For U-100 insulin syringes (if utilized in protocol design):
1 mL = 100 units
Units required are determined by dividing the desired mg amount by the final mg/mL concentration.
Preparation methods may vary depending on intranasal or injectable research protocols.
Semax is studied for its potential influence on:
Neurotrophic Signaling
BDNF expression modeling
Neuroplasticity pathway evaluation
Synaptic-strength modulation
Cognitive & Executive Function
Memory consolidation studies
Attention and focus modeling
Learning-curve analysis
Stress & Neuroprotection
Cortisol-response frameworks
Oxidative stress pathway observation
Ischemic-model signaling analysis
Its mechanism centers on neurotrophic and neurotransmitter modulation rather than direct stimulant or sedative activity.
Within structured research environments, investigators may observe:
Dose-dependent variables
Alertness and cognitive-response shifts
Mood-related signaling changes
Focus variability
Neurophysiologic observations
Sleep-pattern adjustments
Stress-response marker fluctuations
Less frequent observations
Mild headache
Nasal irritation (in intranasal protocols)
Temporary fatigue
Monitoring intensity varies based on protocol duration and study design.
Administration Frequency: Varies by study design (commonly daily in cognitive models)
Common Study Duration: 2–8 weeks
Titration Strategy: Incremental adjustments to evaluate neurochemical response
Researchers may exercise caution when combining Semax with other CNS-modulating agents to prevent overlapping neurochemical pathway effects.
Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.
